Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ADMA Biologics Q2 2024 GAAP EPS $0.13 Beats $0.07 Estimate, Sales $107.191M Beat $86.412M Estimate

Author: Benzinga Newsdesk | August 08, 2024 04:37pm
ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.07 by 85.71 percent. This is a 533.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $107.191 million which beat the analyst consensus estimate of $86.412 million by 24.05 percent. This is a 78.29 percent increase over sales of $60.123 million the same period last year.

Posted In: ADMA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist